REbif FLEXible Dosing in Early Multiple Sclerosis (MS)

Clinical trial NCT00404352 · COMPLETED

Trial details

NCT number: NCT00404352
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2006-11-01
Primary completion: 2010-08-01
Enrollment: 517

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.